Additional Listing

RNS Number : 3353O

Dechra Pharmaceuticals PLC

18 September 2013

 



18 September 2013

Dechra^® Pharmaceuticals PLC

("Dechra" or "the Company")

Additional Listing

An application has been made to the Financial Conduct Authority and the London Stock Exchange for admission to (i) the Official List and (ii) to trading on the London Stock Exchange's markets for a block admission of securities in respect of 211,000 ordinary shares of 1 pence each (the "Shares").

These Shares are being reserved under a block listing and will be issued pursuant to the following schemes:

Scheme	Shares
SAYE Scheme	120,000
Approved Share Option Scheme	31,000
Unapproved Share Option Scheme	60,000

These Shares will rank pari passu with the Company's existing shares in issue.  It is expected that admission will become effective on 23 September 2013. 

For further information, please contact:

Zoe Goulding, Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

LISLLFLVAIITLIV